- Joined
- Jun 8, 2008
- Messages
- 54,123
Yay...some potentially good/hopeful news!
We are still 12-18 months away from a vaccine but this is a ray of hope indeed!!!
NIH clinical trial of remdesivir to treat COVID-19 begins
Study enrolling hospitalized adults with COVID-19 in Nebraska.
www.nih.gov
Science | AAAS
www.sciencemag.org
Clinical Trials Underway to Test Remdesivir for COVID-19 - Pulmonology Advisor
The first US clinical trial to assess the efficacy and safety of an investigational broad-spectrum antiviral agent, remdesivir (Gilead Sciences, Inc.), for the treatment of coronavirus disease 2019.
www.pulmonologyadvisor.com
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Emerging coronaviruses (CoVs) cause severe disease in humans, but no approved therapeutics are available. The CoV nsp14 exoribonuclease (ExoN) has complicated development of antiviral nucleosides due to its proofreading activity. We recently reported that the nucleoside analogue GS-5734...
mbio.asm.org
Role of GS-5734 (Remdesivir) in inhibiting SARS-CoV and MERS-CoV: The expected role of GS-5734 (Remdesivir) in COVID-19 (2019-nCoV) - VYTR hypothesis. | International Journal of Research in Pharmaceutical Sciences
Coronaviruses (CoVs) are enveloped RNA viruses related to the family Coronaviridae, the order Nirdovales, and observed in humans and other mammals. In December 2019, many pneumonia cases reported by patients with unknown causes, mainly associated with seafood and wet animal market in Wuhan...
pharmascope.org
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J Gordon, Egor P Tchesnokov, Joy Y. Feng, Danielle P Porter, Matthias Gotte
www.jbc.org
We are still 12-18 months away from a vaccine but this is a ray of hope indeed!!!